Hospital Da Luz is the First in Portugal to Adopt Genesis Robotic System
20 nov. 2024 08h18 HE
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
Stereotaxis Reports 2024 Third Quarter Financial Results
11 nov. 2024 16h02 HE
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
University of Kansas Medical Center Enhances Robotic Heart Care Program with Genesis Robotic Technology
06 nov. 2024 08h25 HE
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
Stereotaxis to Report Third Quarter 2024 Financial Results on November 11, 2024
23 oct. 2024 09h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation
21 oct. 2024 08h41 HE
|
Stereotaxis, Inc.
ST. LOUIS, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Stereotaxis to Present at Upcoming Investor Conferences
09 sept. 2024 08h40 HE
|
Stereotaxis, Inc.
ST. LOUIS, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David...
Stereotaxis Robotic Technology to be Featured during Heart Rhythm Society’s HRX Congress
03 sept. 2024 08h53 HE
|
Stereotaxis, Inc.
ST. LOUIS, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that its...
Stereotaxis Reports 2024 Second Quarter Financial Results
12 août 2024 16h05 HE
|
Stereotaxis, Inc.
ST. LOUIS, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
Stereotaxis Achieves CE Mark in Europe and Submits 510(k) in the US for Next Generation Robotic System GenesisX
12 août 2024 16h03 HE
|
Stereotaxis, Inc.
Stereotaxis announced it has received CE mark & submitted a 510(k) application for its next-generation, semi-mobile robotic system, GenesisX.
Stereotaxis to Report Second Quarter 2024 Financial Results on August 12, 2024
22 juil. 2024 16h05 HE
|
Stereotaxis, Inc.
ST. LOUIS, July 22, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...